INVEGA SUSTENNA

PALIPERIDONE PALMITATE · Janssen Pharmaceuticals, Inc.

Drug timelines are a Plus or Pro feature.

49 regulatory and trial events tracked for INVEGA SUSTENNA, covering 2009-07-31 to 2025-04-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Transition to the Paliperidone Palmitate 3-Month Formulation In Participants With Schizophrenia Previously Stabilized on the Paliperidone Palmitate 1-Month Formulation [Phase 3]

See pricing